Dasatinib (D) in previously treated metastatic colorectal cancer (mCRC) patients: A phase II trial of the University of Chicago phase II consortium.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. Sharma, K. Wroblewski, M. Kozloff, S. S. Modi, B. G. Sleckman, D. Taber, E. E. Vokes, W. M. Stadler, B. N. Polite, H. L. Kindler
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589115196
